Financial Services
Live Price
Offline$24.12
-0.59% today
1Y Change
+9.13%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Amplify Weight Loss Drug & Treatment ETF (THNR) is an ETF with a market cap of $4.24M and listed on AMEX. The ETF last traded around $24.12 and up 9.1% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Stock Foundry combines THNR price history, dividend context, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THNR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THNR Max Drawdown
-12.06%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for THNR and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.41
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Dec 30, 2025 | Dec 30, 2025 | Dec 31, 2025 | $0.41 | $0.41 | Irregular |
| Dec 30, 2024 | Dec 30, 2024 | Dec 31, 2024 | $0.22 | $0.22 | Special |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.